| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.27 | 2e-09 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.24 | 5e-07 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.18 | 4e-05 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.1 | 0.04 |